Animal data onlyNot FDA approved

Cartalax side effects

Also known as: AED · AED peptide · Ala-Glu-Asp · T-31 · Kartalax · Alanyl-glutamyl-aspartic acid · Cartilage bioregulator

Updated Oct 24, 202620 sources

5 side effects reported for Cartalax: 0 from studies and labels, 5 from users and guides. 5 come with the ways people manage them.

Cartalax overview

Side effects users and guides report

What people post and what dosing guides list. These are reports, not measured rates.

From users and guides5

Community reports, competitor and vendor guides, media.

Redness or itch at the injection site
Occasional and mild, per guides; no study has measured a rate
How people manage it
- Rotate sites (abdomen, thighs, upper arms)
- Inject slowly
- Seek care for a reaction that spreads or worsens
Mild nausea or indigestion
Reported for oral use in Russian practice; usually self-limited
How people manage it
- Usually passes; stop if it persists
Headache
Occasional and mild, per one guide
How people manage it
- Track whether it lines up with dosing days
Mild rash
Rare, per one guide; no anaphylaxis reported
How people manage it
- Stop and seek urgent care for facial or throat swelling, trouble breathing or widespread hives
Dizziness or lightheadedness
Listed as rare on one guide
How people manage it
- Sit or lie down after the dose; stop if it repeats

Who should avoid it, and what not to combine

Pregnancy or breastfeedingCondition
No reproductive toxicology or human safety data exist.
Active bone or cartilage cancerCondition
If the peptide really changes gene activity in cartilage cells, a guide argues that is no place to experiment with a bone or cartilage tumor present. A theoretical concern, not an observed one.
Vials with unclear identity, amount or sterilitySubstance
Research vials are unregulated, and a wrong amount or contamination adds risk that has nothing to do with the peptide.

How much is known

Animal data only

Published work is cell cultures from one connected Russian research network: AED raised cartilage markers in aging stem cells and lowered aging markers in chondrocyte, kidney and skin cell cultures. A rat osteoporosis study tested a T-31 substance on bone density. A 2023 review from the same group says AED was given by mouth to older people with osteoarthritis, but no trial report with numbers is indexed. ClinicalTrials.gov lists no cartalax trials.